Physician profile
Kyle Barjon
NPI 1770042947
$506.31
in general payments reported to CMS, 2019-2025
13 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.68 · 2023: $34.39 · 2024: $70.93 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $125.90 | 2025 | Ova1 |
| Hologic Sales and Service, LLC | $76.95 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $60.67 | 2025 | Veozah |
| Sumitomo Pharma America, INC. | $39.09 | 2024-2025 | Myfembree |
| Medtronic, INC. | $34.39 | 2023 | Ligasure |
| Channel Medsystems, INC. | $28.85 | 2025 | |
| Sage Therapeutics, LLC | $27.75 | 2024 | |
| Pfizer INC. | $25.72 | 2025 | |
| Organon LLC | $25.02 | 2024 | |
| Ethicon US, LLC | $22.87 | 2025 | Surgicel Nu-Knit, Stratafix, Vistaseal |
| Coopersurgical, INC. | $17.68 | 2020 | |
| Abbvie INC. | $14.72 | 2025 | |
| Mayne Pharma Commercial LLC | $6.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Barjon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.